The trademark MYSSAL was filed by Mercury Pharma Group Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on June 16, 2020, and received one opposition filed on September 6, 2020 by NEOPHARMED GENTILI S.p.A. on Likelihood of confusion. the opponent was represented by CON LOR S.P.A. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 6, 2020
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 19, 2021.